Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 131-138 of 138 for

Edit search filters
  1. A Study to Develop a Biorepository of Blood Samples from Cancer Patients Participating in the Gemini (IRB 19-006717) Protocol

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  2. The Circulating Cell-free Genome Atlas Study

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. Reporting of Side Effects Among Stage III and IV Melanoma Patients Treated with Immune Checkpoint Inhibitors

    Rochester, MN

  4. Diagnosing Lymphangioleiomyomatosis from Glycoprotein Non-Metastatic Melanoma Protein B

    Rochester, MN

  5. Congenital Heart Disease Skin Punch Biopsy Sample Collection

    Rochester, MN

  6. A Study of Immune System Activity Cycles in Patients with Surgically Removed Early Stage Melanoma

    Rochester, MN

  7. Therapeutic Drug Monitoring of Pembrolizumab and Nivolumab to Determine Dosages for Cancer Treatment

    Rochester, MN

  8. Defining the Immunologic Profile of Sentinel Lymph Nodes and Identifying the Mechanisms Responsible for Immunosuppression

    Rochester, MN, Jacksonville, FL

.

Mayo Clinic Footer